Ceballos-González Sergio, Torres-Cantero César, Trujillo-Hernández Benjamín, Muñiz Jesús, Huerta Miguel, Trujillo Xochitl, Vásquez Clemente
Servicio de Urología, Hospital General de Zona y Medicina Familiar No. 1, IMSS, Colima, Colima, México.
Gac Med Mex. 2006 Mar-Apr;142(2):121-4.
To compare clinical improvement between treatment with metilprednisolone aceponate vs. betamethasone dipropionate among children with nonretractable prepuce.
Between August 2001 and November 2002, we carried out a double blind and controlled clinical trial in 34 children with a diagnosis of nonretracable prepuce. Children were randomly assigned to one of the following groups and topical treatment was administered: Group A; metilprednisolone aceponate 0. I 1% and Group B; betamethasone dipropionate 0.05%.
Improvement was noted in 88.2% of our sample studied; (n= 15) children from group A and 76.4% (n= 13) childrenfrom group B; however, we did not observe a significant difference when comparing percentages between the two groups (chi2 = 0.2; p = 0.6).
The percentage of clinical improvement was similar between the two groups of topical steroid treatment administered.
比较用醋丙甲泼尼龙与二丙酸倍他米松治疗小儿包茎的临床效果。
2001年8月至2002年11月，我们对34例诊断为包茎的患儿进行了一项双盲对照临床试验。将患儿随机分为以下组并给予局部治疗：A组，0.1%醋丙甲泼尼龙；B组，0.05%二丙酸倍他米松。
在我们研究的样本中，88.2%（n = 15）的A组患儿和76.4%（n = 13）的B组患儿有改善；然而，比较两组的百分比时，我们未观察到显著差异（χ² = 0.2；p = 0.6）。
两组局部用类固醇治疗的临床改善百分比相似。
